Skip to content

Early Determinants of Multidimensional Outcome at School Age After Neonatal Arterial Ischemic Stroke

Early Determinants of Multidimensional Outcome at School Age After Neonatal Arterial Ischemic Stroke (AVCnn7 Years Study)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02511249
Enrollment
80
Registered
2015-07-30
Start date
2010-10-31
Completion date
2013-11-30
Last updated
2015-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Infarction

Keywords

neonatal arterial ischemic stroke, language development, global intellectual functioning, motor abilities

Brief summary

While perinatal ischemic stroke is the most frequent form of childhood stroke, early determinants of outcome remain poorly understood. Two main structural biases limit the accuracy of most studies: heterogeneity of the population and short follow-up. Perinatal ischemic stroke includes several conditions that differ in pathophysiology and timing of occurrence. Yet, it is not surprising that risk factors and outcome depend primarily on the type of stroke. Age at evaluation also plays a major role after a neonatal insult. Even though the original lesion is static and focal in perinatal stroke, its consequences grow over time within the maturing brain and affect all fields of neurodevelopment. The objective of the AVCnn study was to delineate the determinants, clinical and imaging presentation, mechanism, and long term outcome of a category of perinatal stroke (neonatal arterial ischemic stroke: NAIS). This led to the AVCnn cohort, which now gives us the opportunity to regularly monitor a large cohort of children having suffered an NAIS.

Detailed description

Between November 2003 and October 2006, a cohort of one hundred symptomatic term newborns with AIS confirmed through early brain imaging has been constituted. Regular contacts with the families and their local physician have been maintained since enrollment. In 2010, families were asked through postal mail to participate in the 7 years assessment (AVCnn7ans). Those who accepted were contacted by phone by the coordinators of the study during the months preceding the child's seventh birthday and invited to attend a presentation in person of the current project. This evaluation took place face-to-face for a whole day in a medical setting close to the family residence. The evaluation team included a neuropsychologist, a speech therapist and either a pediatric neurologist or a pediatric physical and rehabilitation medicine practitioner.

Interventions

None listed

Sponsors

Ministry for Health and Solidarity, France
CollaboratorOTHER_GOV
University Hospital of Saint-Etienne
CollaboratorOTHER
Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* Belonging to the AVCnn cohort

Exclusion criteria

* Lost to follow-up at 7 years. * Refusal to participate in the current assessment.

Design outcomes

Primary

MeasureTime frameDescription
Epileptic outcomeat 7 yearsOccurrence of two or more afebrile unprovoked seizures after the neonatal period or, in the event of single afebrile unprovoked seizure, when it was decided to introduce antiepileptic treatment
Academic outcome (composite measure)at 7 yearsGrade retention or the need for specific and individualized support in mainstream school or inclusion in a special school.
Neurodevelopmental outcome at 7 yearsat 7 yearspermanent abnormal tone or decreased strength associated with a patent functional deficit

Secondary

MeasureTime frameDescription
Cerebral imaging ancillary studyat 7 yearsAnatomic post-lesional connectivity.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026